Colorectal Delivery and Retention of PEG-Amprenavir-Bac7 Nanoconjugates—proof of Concept for HIV Mucosal Pre-Exposure Prophylaxis

Drug Delivery and Translational Research - United States
doi 10.1007/s13346-015-0269-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

HIV Pre-Exposure Prophylaxis

CMAJ
Medicine
2014English

Tenofovir-Based Pre-Exposure Prophylaxis for HIV Prevention

Current Opinion in Infectious Diseases
Infectious DiseasesMicrobiology
2012English

Canadian Guideline on HIV Pre-Exposure Prophylaxis and Nonoccupational Postexposure Prophylaxis

CMAJ
Medicine
2018English

HIV Pre-Exposure Prophylaxis (PrEP): Effective but Controversial

Trends in Urology & Men's Health
2017English

Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Perspectives

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2017English

Social Judgments of Sexual Behavior and Use of HIV Pre-Exposure Prophylaxis

Social Cognition
DevelopmentalEducational PsychologySocial Psychology
2020English

“Fusion and Binding Inhibition” Key Target for HIV-1 Treatment and Pre-Exposure Prophylaxis: Targets, Drug Delivery and Nanotechnology Approaches

Drug Delivery
MedicinePharmaceutical Science
2017English

Antiretroviral-Based HIV-1 Prevention: Antiretroviral Treatment and Pre-Exposure Prophylaxis

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Portuguese Health Care Providers’ Knowledge, Attitudes, and Acceptability of HIV Pre-Exposure Prophylaxis

HIV and AIDS Review
EpidemiologyInfectious Diseases
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy